CPT-Text for Post-Traumatic Stress Disorder
(CPT-TEXT Trial)
Trial Summary
What is the purpose of this trial?
There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based therapy holds promise to increase capacity and reduce barriers to delivering evidence-based treatments (EBTs), but ongoing engagement in digital mental health interventions is low. This study will compare a texting-based EBT for PTSD to culturally-informed texting-based treatment for PTSD as usual, and it will also compare a unique incentive strategy to typical platform reminders aimed to prevent early discontinuation in therapy. This online study is open to individuals who live in 18 different states.
Do I need to stop my current medications for this PTSD trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on texting-based therapy, so you might not need to change your medication routine, but it's best to confirm with the trial organizers.
What data supports the effectiveness of the treatment CPT-Text for Post-Traumatic Stress Disorder?
Cognitive Processing Therapy (CPT) has been shown to significantly reduce PTSD symptoms in various populations, including sexual assault survivors and combat veterans, with improvements maintained over time. Studies indicate that CPT is effective in diverse settings and cultural adaptations, suggesting its potential effectiveness when delivered via text.12345
Is CPT-Text safe for humans?
Cognitive Processing Therapy (CPT) is generally considered safe for treating post-traumatic stress disorder (PTSD) in various settings, including telehealth and culturally adapted formats. While specific safety data for CPT-Text is not available, CPT itself is widely regarded as a safe treatment.13567
How is the CPT-Text treatment for PTSD different from other treatments?
CPT-Text is unique because it delivers Cognitive Processing Therapy (CPT) through text messages, making it more accessible and convenient for patients who may not be able to attend in-person sessions. This approach allows for culturally informed trauma treatment, which can be tailored to the individual's cultural background and needs.13467
Research Team
Shannon Wiltsey-Stirman, PhD
Principal Investigator
Stanford University
Katy Dondanville, PsyD
Principal Investigator
University of Texas Health Sciences Center for San Antonio
Eligibility Criteria
This trial is for adults in the US with significant PTSD symptoms that started or worsened during COVID-19. Participants must score 33+ on the PCL-5, have experienced a Criterion A event, be registered on Talkspace for therapy, and own a texting device. It's not open to those with acute psychosis, substance abuse needing higher care level, or high suicide risk.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Onboarding
Participants undergo onboarding with their therapist, including introduction and establishing treatment goals
Treatment
Participants receive active texting intervention for PTSD using CPT-Text or CITT over a secure platform
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- CPT-Text
- Culturally Informed Trauma Treatment (CITT)
- Reminder as Usual
- Retention Incentive
- Texting as Usual
CPT-Text is already approved in United States for the following indications:
- Posttraumatic Stress Disorder (PTSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Collaborator
Talkspace
Industry Sponsor
National Institute of Mental Health (NIMH)
Collaborator
University of Pennsylvania
Collaborator